Moderna, Inc. (MRNA) Revenue 2016–2025
Moderna, Inc. (MRNA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.9BFY2025 · since FY2016: $108.4M → $1.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9B | -39.9% |
| FY2024 | $3.2B | -52.7% |
| FY2023 | $6.8B | -64.4% |
| FY2022 | $19.3B | +4.3% |
| FY2021 | $18.5B | +2200.2% |
| FY2020 | $803.0M | +1233.7% |
| FY2019 | $60.2M | -55.4% |
| FY2018 | $135.1M | -34.4% |
| FY2017 | $205.8M | +89.9% |
| FY2016 | $108.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice